8TRG image
Deposition Date 2023-08-09
Release Date 2023-11-15
Last Version Date 2024-10-30
Entry Detail
PDB ID:
8TRG
Title:
Structure of full-length LexA bound to a RecA filament
Biological Source:
Source Organism:
Escherichia coli (Taxon ID: 562)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.93 Å
Aggregation State:
FILAMENT
Reconstruction Method:
HELICAL
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Protein RecA
Gene (Uniprot):recA
Chain IDs:A, B, C, D, E, F, G, H
Chain Length:379
Number of Molecules:8
Biological Source:Escherichia coli
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:LexA repressor
Gene (Uniprot):lexA
Mutagens:K156A
Chain IDs:I, J
Chain Length:205
Number of Molecules:2
Biological Source:Escherichia coli
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (27-MER)
Chain IDs:K (auth: L)
Chain Length:27
Number of Molecules:1
Biological Source:Escherichia coli
Primary Citation
The LexA-RecA* structure reveals a cryptic lock-and-key mechanism for SOS activation.
Nat.Struct.Mol.Biol. 31 1522 1531 (2024)
PMID: 38755298 DOI: 10.1038/s41594-024-01317-3

Abstact

The bacterial SOS response plays a key role in adaptation to DNA damage, including genomic stress caused by antibiotics. SOS induction begins when activated RecA*, an oligomeric nucleoprotein filament that forms on single-stranded DNA, binds to and stimulates autoproteolysis of the repressor LexA. Here, we present the structure of the complete Escherichia coli SOS signal complex, constituting full-length LexA bound to RecA*. We uncover an extensive interface unexpectedly including the LexA DNA-binding domain, providing a new molecular rationale for ordered SOS gene induction. We further find that the interface involves three RecA subunits, with a single residue in the central engaged subunit acting as a molecular key, inserting into an allosteric binding pocket to induce LexA cleavage. Given the pro-mutagenic nature of SOS activation, our structural and mechanistic insights provide a foundation for developing new therapeutics to slow the evolution of antibiotic resistance.

Legend

Protein

Chemical

Disease

Primary Citation of related structures